Urolithin A: The Next NAD+?
Urolithin A is a small molecule made by certain gut bacteria when you eat polyphenols found in pomegranates, berries, walnuts, and some teas. The molecule itself does not come from food directly — your gut microbes have to convert plant compounds called ellagitannins into it. That bacterial step is why urolithin A is unusual: two people can eat the same pomegranate and end up with very different blood levels.
Researchers got interested in urolithin A because of mitophagy — the housekeeping process that clears out broken mitochondria, the small "power plants" inside our cells. Mitophagy slows down with age and may play a role in muscle weakness, fatigue, and some metabolic diseases. Urolithin A appears to switch mitophagy back on in lab studies.
The Science Is Genuinely Interesting
The mitophagy story is legitimate biology. A 2019 randomized trial published in Nature Metabolism (Andreux et al., n=60 healthy older adults, ages 61–85, 28 days) found that 500 mg or 1,000 mg per day of urolithin A produced a clear molecular signature of better mitochondrial health in muscle and blood, with no safety problems. A 2022 randomized trial in Cell Reports Medicine (Liu et al., 4 months) found 1,000 mg per day improved muscle strength in middle-aged and older adults compared with placebo. These are well-conducted trials, not marketing papers.
Mitopure/Amazentis trial data, in plain numbers
The Hype Gets Ahead of the Evidence
The problem is the gap between what has been shown and what is sold. Marketing pages call urolithin A an "anti-aging supplement," "longevity molecule," and "mitochondria recharger." Those phrases go far beyond what two short-duration trials in older adults can support. Urolithin A has not been shown to extend human lifespan, prevent any age-related disease, or produce benefits in young, healthy adults. The strength gains in human trials are real but modest — on the order of 10–15% on a single endurance task, not a transformation. The benefits in younger, fitter people are unstudied.
The Producer Problem
Roughly 30–40% of adults make significant urolithin A on their own when they eat ellagitannin-rich foods. The rest carry a different mix of gut microbes and produce little or none. Supplementing with the finished molecule sidesteps that gap, but it also means most "natural" claims about getting urolithin A from a glass of pomegranate juice only work for a minority of people. There is no cheap, widely available test to find out which group you are in.
The Cost Problem
The leading urolithin A product, Mitopure (Timeline/Amazentis), costs about $60–$100 per month for the 500–1,000 mg/day doses used in trials. For most people that is a steep price for a likely small benefit, especially if you are under 60 and exercising regularly. Resistance training and protein intake remain the proven paths to muscle strength at any age, and they are free.
Bottom line: urolithin A is interesting science with a narrow, real benefit in older adults — not the universal longevity drug the marketing implies.
Sources
- Andreux PA, Blanco-Bose W, Ryu D, et al. "The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans." Nature Metabolism, 2019;1(6):595-603. PMID: 32694802. DOI: 10.1038/s42255-019-0073-4.
- Liu S, D'Amico D, Shankland E, et al. "Effect of urolithin A supplementation on muscle endurance and mitochondrial health in older adults: a randomized clinical trial." JAMA Network Open, 2022;5(1):e2144279. PMID: 35080606. DOI: 10.1001/jamanetworkopen.2021.44279.
- Singh A, D'Amico D, Andreux PA, et al. "Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability in healthy adults to achieve consistent levels across the population." European Journal of Clinical Nutrition, 2022;76(2):297-308. PMID: 33837301. DOI: 10.1038/s41430-021-00950-1.
- Tomás-Barberán FA, González-Sarrías A, García-Villalba R, et al. "Urolithins, the rescue of 'old' metabolites to understand a 'new' concept: metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status." Molecular Nutrition & Food Research, 2017;61(1). PMID: 27158799. DOI: 10.1002/mnfr.201500901.
- Ryu D, Mouchiroud L, Andreux PA, et al. "Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents." Nature Medicine, 2016;22(8):879-888. PMID: 27400265. DOI: 10.1038/nm.4132.